Thromboembolic risks in patients with COVID-19: major concern to consider in our management

COVID-19 pandemic is an emergent cardiovascular risk factor and a major cause of mortality worldwide. Thromboembolism is highly suspected as a leading cause of death in these patients through vascular inflammation caused by SARS COV2. Until now there is no real treatment of COVID-19 and many propose...

Descripción completa

Detalles Bibliográficos
Autores principales: Temgoua, Mazou Ngou, Kuaté, Liliane Mfeukeu, Ngatchou, William, Sibetcheu, Aurelie, Toupendi, Zouliatou Nzina, Belobo, Grace, Ossa, Alice, Kingue, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2020
Materias:
Letter to the Editors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266474/
https://www.ncbi.nlm.nih.gov/pubmed/32528621
http://dx.doi.org/10.11604/pamj.2020.35.2.22945
_version_ 1783541317254512640
author Temgoua, Mazou Ngou
Kuaté, Liliane Mfeukeu
Ngatchou, William
Sibetcheu, Aurelie
Toupendi, Zouliatou Nzina
Belobo, Grace
Ossa, Alice
Kingue, Samuel
author_facet Temgoua, Mazou Ngou
Kuaté, Liliane Mfeukeu
Ngatchou, William
Sibetcheu, Aurelie
Toupendi, Zouliatou Nzina
Belobo, Grace
Ossa, Alice
Kingue, Samuel
author_sort Temgoua, Mazou Ngou
collection PubMed
description COVID-19 pandemic is an emergent cardiovascular risk factor and a major cause of mortality worldwide. Thromboembolism is highly suspected as a leading cause of death in these patients through vascular inflammation caused by SARS COV2. Until now there is no real treatment of COVID-19 and many proposed drugs are under clinical trials. Considering the high incidence of thromboembolic events in critically ill patients with COVID-19, prevention of this disorder should be essential in order to reduce mortality in these patients.
format Online
Article
Text
id pubmed-7266474
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-72664742020-06-10 Thromboembolic risks in patients with COVID-19: major concern to consider in our management Temgoua, Mazou Ngou Kuaté, Liliane Mfeukeu Ngatchou, William Sibetcheu, Aurelie Toupendi, Zouliatou Nzina Belobo, Grace Ossa, Alice Kingue, Samuel Pan Afr Med J Letter to the Editors COVID-19 pandemic is an emergent cardiovascular risk factor and a major cause of mortality worldwide. Thromboembolism is highly suspected as a leading cause of death in these patients through vascular inflammation caused by SARS COV2. Until now there is no real treatment of COVID-19 and many proposed drugs are under clinical trials. Considering the high incidence of thromboembolic events in critically ill patients with COVID-19, prevention of this disorder should be essential in order to reduce mortality in these patients. The African Field Epidemiology Network 2020-04-27 /pmc/articles/PMC7266474/ /pubmed/32528621 http://dx.doi.org/10.11604/pamj.2020.35.2.22945 Text en © Mazou Ngou Temgoua et al. http://creativecommons.org/licenses/by/2.0/ The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editors
Temgoua, Mazou Ngou
Kuaté, Liliane Mfeukeu
Ngatchou, William
Sibetcheu, Aurelie
Toupendi, Zouliatou Nzina
Belobo, Grace
Ossa, Alice
Kingue, Samuel
Thromboembolic risks in patients with COVID-19: major concern to consider in our management
title Thromboembolic risks in patients with COVID-19: major concern to consider in our management
title_full Thromboembolic risks in patients with COVID-19: major concern to consider in our management
title_fullStr Thromboembolic risks in patients with COVID-19: major concern to consider in our management
title_full_unstemmed Thromboembolic risks in patients with COVID-19: major concern to consider in our management
title_short Thromboembolic risks in patients with COVID-19: major concern to consider in our management
title_sort thromboembolic risks in patients with covid-19: major concern to consider in our management
topic Letter to the Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266474/
https://www.ncbi.nlm.nih.gov/pubmed/32528621
http://dx.doi.org/10.11604/pamj.2020.35.2.22945
work_keys_str_mv AT temgouamazoungou thromboembolicrisksinpatientswithcovid19majorconcerntoconsiderinourmanagement
AT kuatelilianemfeukeu thromboembolicrisksinpatientswithcovid19majorconcerntoconsiderinourmanagement
AT ngatchouwilliam thromboembolicrisksinpatientswithcovid19majorconcerntoconsiderinourmanagement
AT sibetcheuaurelie thromboembolicrisksinpatientswithcovid19majorconcerntoconsiderinourmanagement
AT toupendizouliatounzina thromboembolicrisksinpatientswithcovid19majorconcerntoconsiderinourmanagement
AT belobograce thromboembolicrisksinpatientswithcovid19majorconcerntoconsiderinourmanagement
AT ossaalice thromboembolicrisksinpatientswithcovid19majorconcerntoconsiderinourmanagement
AT kinguesamuel thromboembolicrisksinpatientswithcovid19majorconcerntoconsiderinourmanagement

Ejemplares similares